Stay updated on Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.

Latest updates to the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a 403 Forbidden error page with a minimal header and footer, replacing the previous study content and navigation.SummaryDifference19%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the prior Revision: v3.6.5. This indicates a new version of the page's revision metadata.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the record's metadata. No substantive study details appear to have changed as part of this update.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This change represents a metadata update to the page version and does not alter the study content or visible information.SummaryDifference0.1%

- Check89 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the ClinicalTrials.gov entry. There is no indication of changes to study data or eligibility criteria from this revision.SummaryDifference0.1%

- Check96 days agoChange DetectedThe revision label on the page has been updated from v3.6.0 to v3.6.2, indicating a small patch to the page; no substantive content changes are evident.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Psilocybin Cancer Major Depressive Disorder Clinical Trial page.